Table 1 Showed the demographic data of all patients
Total (n = 44) | Palliative (n = 22) | TES (n = 22) | p-value | |
|---|---|---|---|---|
Sex | 0.763 | |||
Male | 21 (47.73) | 11 (50.00) | 10 (45.45) | |
Female | 23 (52.27) | 11 (50.00) | 12 (54.55) | |
Age; mean(sd) | 55.75 (11.51) | 58.73 (11.96) | 52.77 (10.48) | 0.086 |
Origin | 0.462 | |||
Breat | 9 (20.45) | 5 (22.73) | 4 (18.18) | |
Lung | 11 (25.00) | 4 (18.18) | 7 (31.82) | |
Liver | 2 (4.55) | - | 2 (9.09) | |
CCA | 8 (18.18) | 5 (22.73) | 3 (13.64) | |
Colon | 4 (9.09) | 3 (13.64) | 1 (4.55) | |
RCC | 2 (4.55) | 1 (4.55) | 1 (4.55) | |
Sarcoma | 1 (2.27) | - | 1 (4.55) | |
Thyroid | 1 (2.27) | - | 1 (4.55) | |
Bladder | 1 (2.27) | 1 (4.55) | - | |
Endometrium | 3 (6.82) | 1 (4.55) | 2 (9.09) | |
Prostate | 2 (4.55) | 2 (9.09) | - | |
Hct (pre-op) mean(sd) | 36.83 (4.90) | 35.94 (4.85) | 37.73 (4.89) | 0.228 |
Tomita score; mean(sd) | 5.25 (2.23) | 5.82 (2.54) | 4.68 (1.76) | 0.092 |
Tokuhashi score; mean(sd) | 8.20 (2.69) | 7.82 (2.52) | 8.59 (2.86) | 0.347 |
SORG total point mean(sd) | 144.56 (20.68) | 145.9(20.57) | 143.18(21.19) | 0.091 |
ECOG | 0.075 | |||
0 | 1 (2.27) | 1 (4.55) | - | |
1 | 6 (13.64) | 3 (13.64) | 3 (13.64) | |
2 | 7 (15.91) | 5 (22.73) | 2 (9.09) | |
3 | 14 (31.82) | 3 (13.64) | 11 (50.00) | |
4 | 16 (36.36) | 10 (45.45) | 6 (27.27) | |
Pre op Frankel scale | 0.727 | |||
A | 8 (18.18) | 3 (13.64) | 5 (22.73) | |
B | 3 (6.82) | 2 (9.09) | 1 (4.55) | |
C | 10 (22.73) | 6 (27.27) | 4 (18.18) | |
D | 10 (22.73) | 6 (27.27) | 4 (18.18) | |
E | 8 (36.36) | 5 (22.73) | 8 (36.36) | |
ASIA | 0.116 | |||
A | 8 (18.18) | 3 (13.64) | 5 (22.73) | |
B | 1 (2.27) | - | 1 (4.55) | |
C | 8 (18.18) | 7 (31.82) | 1 (4.55) | |
D | 13 (29.55) | 7 (31.82) | 6 (27.27) | |
E | 14 (31.82) | 5 (22.73) | 9 (40.91) |